Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BRUKER CORPBRKR · Entity 3609 | Director | February 15, 2026 | February 18, 2026 |
| CASTLE BIOSCIENCES INCCSTL · Entity 359 | Director | July 16, 2020 | July 28, 2020 |
| VERACYTE, INC.VCYT · Entity 2018 | Director | June 02, 2023 | June 06, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BRUKER CORP
Report date February 15, 2026 · Filed February 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 17,847 |
Reported balance
After 2026-02-15 transaction · row 1
1 source rowRow 1 · 2026-02-15 · Grant · Acquired 4,520 · Balance 17,847 F1: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on February 15, 2027. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock. |
Filing footnotes · ownership attribution and instrument terms
F1: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on February 15, 2027. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock.
CASTLE BIOSCIENCES INC
Report date July 16, 2020 · Filed July 28, 2020 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy trust | 21,723 |
Last balance in matching sequence
After 2020-07-16 transaction · row 3
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
3 source rowsRow 1 · 2020-07-16 · Sale · Disposed 1,228 · Balance 23,495 F1: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on March 17, 2020. F2: This transaction was executed in multiple trades at prices ranging from $42.51 to $43.14, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3: Held by the Bonnie H. Anderson Living Trust, or the Anderson Trust. The Reporting Person is the trustee of the Anderson Trust. Row 2 · 2020-07-16 · Sale · Disposed 1,763 · Balance 21,732 F1: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on March 17, 2020. F4: This transaction was executed in multiple trades at prices ranging from $43.61 to $44.52, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3: Held by the Bonnie H. Anderson Living Trust, or the Anderson Trust. The Reporting Person is the trustee of the Anderson Trust. Row 3 · 2020-07-16 · Sale · Disposed 9 · Balance 21,723 F1: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on March 17, 2020. F3: Held by the Bonnie H. Anderson Living Trust, or the Anderson Trust. The Reporting Person is the trustee of the Anderson Trust. |
Filing footnotes · ownership attribution and instrument terms
F1: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on March 17, 2020.
F2: This transaction was executed in multiple trades at prices ranging from $42.51 to $43.14, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3: Held by the Bonnie H. Anderson Living Trust, or the Anderson Trust. The Reporting Person is the trustee of the Anderson Trust.
F4: This transaction was executed in multiple trades at prices ranging from $43.61 to $44.52, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
VERACYTE, INC.
Report date June 02, 2023 · Filed June 06, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 41,377 |
Reported balance
After 2023-06-02 transaction · row 1
1 source rowRow 1 · 2023-06-02 · Tax withholding · Disposed 1,304 · Balance 41,377 F1: The reporting person is reporting the withholding of 812 and 492 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 2,062 and 1,250 Restricted Stock Units, respectively, granted on February 28, 2020 and February 26, 2021, respectively, and does not represent a sale by the reporting person. |
| Common StockSEC Table I · non-derivative | IndirectThe Bonnie H. Anderson Living Trust | 134,800 |
Reported balance
Holding disclosure · report date 2023-06-02 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 134,800 |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person is reporting the withholding of 812 and 492 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 2,062 and 1,250 Restricted Stock Units, respectively, granted on February 28, 2020 and February 26, 2021, respectively, and does not represent a sale by the reporting person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 06, 2020 Filed Aug 12, 2020 22:37 UTC | VERACYTE, INC. VCYT · Entity 2018 | GiftCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-017701 · rdgdoc.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 247,207 Read SEC document |
| July 30, 2020 Filed Jul 31, 2020 20:32 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 11,365 | $0.00 Strike: $8.86 | $0.00 |
DisclosureSEC source: 0001437749-20-016181 · rdgdoc.xml · derivative · entry 4 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,312 Underlying: Common Stock · 11,365 shares Expires 2025-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019 F3 · derivative.exercise_date: The option is fully vested. Read SEC document |
| July 30, 2020 Filed Jul 31, 2020 20:32 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 11,365 | $32.24 | $366,398.51 |
DisclosureSEC source: 0001437749-20-016181 · rdgdoc.xml · nonDerivative · entry 2 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,207 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019 F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $32.01 to $32.55. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| July 30, 2020 Filed Jul 31, 2020 20:32 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 11,365 | $8.86 | $100,693.90 |
DisclosureSEC source: 0001437749-20-016181 · rdgdoc.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 283,572 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019 Read SEC document |
| July 23, 2020 Filed Jul 27, 2020 21:04 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 3,280 | $0.00 Strike: $8.86 | $0.00 |
DisclosureSEC source: 0001437749-20-015789 · rdgdoc.xml · derivative · entry 4 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199,677 Underlying: Common Stock · 3,280 shares Expires 2025-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option is fully vested. Read SEC document |
| July 23, 2020 Filed Jul 27, 2020 21:04 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 3,280 | $32.04 | $105,106.29 |
DisclosureSEC source: 0001437749-20-015789 · rdgdoc.xml · nonDerivative · entry 2 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,207 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019 F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $32.00 to $32.14. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| July 23, 2020 Filed Jul 27, 2020 21:04 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 3,280 | $8.86 | $29,060.80 |
DisclosureSEC source: 0001437749-20-015789 · rdgdoc.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275,487 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019 Read SEC document |
| July 22, 2020 Filed Jul 22, 2020 22:09 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 100 | $0.00 Strike: $8.86 | $0.00 |
DisclosureSEC source: 0001437749-20-015554 · rdgdoc.xml · derivative · entry 12 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,519 Underlying: Common Stock · 100 shares Expires 2025-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. F4 · derivative.exercise_date: The option is fully vested. Read SEC document |
| July 22, 2020 Filed Jul 22, 2020 22:09 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 100 | $32.00 | $3,200.00 |
DisclosureSEC source: 0001437749-20-015554 · rdgdoc.xml · nonDerivative · entry 7 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,207 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. Read SEC document |
| July 22, 2020 Filed Jul 22, 2020 22:09 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 100 | $8.86 | $886.00 |
DisclosureSEC source: 0001437749-20-015554 · rdgdoc.xml · nonDerivative · entry 6 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,307 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. Read SEC document |
| July 22, 2020 Filed Jul 27, 2020 21:00 UTC Amendment | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 100 | $0.00 Strike: $8.86 | $0.00 |
DisclosureSEC source: 0001437749-20-015787 · rdgdoc.xml · derivative · entry 12 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202,957 Underlying: Common Stock · 100 shares Expires 2025-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. F4 · derivative.exercise_date: The option is fully vested. F6 · balance_after: The total reported in Column 9 has been adjusted to correct an understatement of total holdings by 98,438 shares as reflected in Form 4 filed on July 22, 2020. Read SEC document |
| July 22, 2020 Filed Jul 27, 2020 21:00 UTC Amendment | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 100 | $32.00 | $3,200.00 |
DisclosureSEC source: 0001437749-20-015787 · rdgdoc.xml · nonDerivative · entry 7 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,207 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. Read SEC document |
| July 22, 2020 Filed Jul 27, 2020 21:00 UTC Amendment | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 100 | $8.86 | $886.00 |
DisclosureSEC source: 0001437749-20-015787 · rdgdoc.xml · nonDerivative · entry 6 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,307 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. Read SEC document |
| July 21, 2020 Filed Jul 22, 2020 22:09 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 3,447 | $0.00 Strike: $8.86 | $0.00 |
DisclosureSEC source: 0001437749-20-015554 · rdgdoc.xml · derivative · entry 11 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,619 Underlying: Common Stock · 3,447 shares Expires 2025-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. F4 · derivative.exercise_date: The option is fully vested. Read SEC document |
| July 21, 2020 Filed Jul 22, 2020 22:09 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 3,447 | $32.09 | $110,613.54 |
DisclosureSEC source: 0001437749-20-015554 · rdgdoc.xml · nonDerivative · entry 5 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,207 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $32.00 to $32.25. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| July 21, 2020 Filed Jul 22, 2020 22:09 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 3,447 | $8.86 | $30,540.42 |
DisclosureSEC source: 0001437749-20-015554 · rdgdoc.xml · nonDerivative · entry 4 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275,654 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. Read SEC document |
| July 21, 2020 Filed Jul 27, 2020 21:00 UTC Amendment | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 3,447 | $0.00 Strike: $8.86 | $0.00 |
DisclosureSEC source: 0001437749-20-015787 · rdgdoc.xml · derivative · entry 11 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,057 Underlying: Common Stock · 3,447 shares Expires 2025-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. F4 · derivative.exercise_date: The option is fully vested. F6 · balance_after: The total reported in Column 9 has been adjusted to correct an understatement of total holdings by 98,438 shares as reflected in Form 4 filed on July 22, 2020. Read SEC document |
| July 21, 2020 Filed Jul 27, 2020 21:00 UTC Amendment | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 3,447 | $32.09 | $110,613.54 |
DisclosureSEC source: 0001437749-20-015787 · rdgdoc.xml · nonDerivative · entry 5 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,207 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $32.00 to $32.25. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| July 21, 2020 Filed Jul 27, 2020 21:00 UTC Amendment | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 3,447 | $8.86 | $30,540.42 |
DisclosureSEC source: 0001437749-20-015787 · rdgdoc.xml · nonDerivative · entry 4 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275,654 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. Read SEC document |
| July 20, 2020 Filed Jul 22, 2020 22:09 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 18,496 | $0.00 Strike: $8.86 | $0.00 |
DisclosureSEC source: 0001437749-20-015554 · rdgdoc.xml · derivative · entry 10 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,066 Underlying: Common Stock · 18,496 shares Expires 2025-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. F4 · derivative.exercise_date: The option is fully vested. Read SEC document |
| July 20, 2020 Filed Jul 22, 2020 22:09 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 1,853 | $0.00 Strike: $4.00 | $0.00 |
DisclosureSEC source: 0001437749-20-015554 · rdgdoc.xml · derivative · entry 9 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 1,853 shares Expires 2023-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. F4 · derivative.exercise_date: The option is fully vested. F5 · balance_after: On February 5, 2013, the Reporting Person was issued 3 stock options which have different vesting dates, all of which are vested. These options include: (1) 112,500, of which 25,000 options remain, (2) 12,500, of which none remain and (3) 24,112, of which 1,853 were exercised on 07/20/2020 and none remain. Read SEC document |
| July 20, 2020 Filed Jul 22, 2020 22:09 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 20,349 | $32.04 | $651,910.74 |
DisclosureSEC source: 0001437749-20-015554 · rdgdoc.xml · nonDerivative · entry 3 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,207 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $32.00 to $32.34. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| July 20, 2020 Filed Jul 22, 2020 22:09 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 18,496 | $8.86 | $163,874.56 |
DisclosureSEC source: 0001437749-20-015554 · rdgdoc.xml · nonDerivative · entry 2 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 292,556 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. Read SEC document |
| July 20, 2020 Filed Jul 22, 2020 22:09 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 1,853 | $4.00 | $7,412.00 |
DisclosureSEC source: 0001437749-20-015554 · rdgdoc.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,060 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. Read SEC document |
| July 20, 2020 Filed Jul 27, 2020 21:00 UTC Amendment | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 18,496 | $0.00 Strike: $8.86 | $0.00 |
DisclosureSEC source: 0001437749-20-015787 · rdgdoc.xml · derivative · entry 10 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,504 Underlying: Common Stock · 18,496 shares Expires 2025-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. F4 · derivative.exercise_date: The option is fully vested. F6 · balance_after: The total reported in Column 9 has been adjusted to correct an understatement of total holdings by 98,438 shares as reflected in Form 4 filed on July 22, 2020. Read SEC document |
| July 20, 2020 Filed Jul 27, 2020 21:00 UTC Amendment | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 1,853 | $0.00 Strike: $4.00 | $0.00 |
DisclosureSEC source: 0001437749-20-015787 · rdgdoc.xml · derivative · entry 9 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 1,853 shares Expires 2023-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. F4 · derivative.exercise_date: The option is fully vested. F5 · balance_after: On February 5, 2013, the Reporting Person was issued 3 stock options which have different vesting dates, all of which are vested. These options include: (1) 112,500, of which 25,000 options remain, (2) 12,500, of which none remain and (3) 24,112, of which 1,853 were exercised on 07/20/2020 and none remain. Read SEC document |
| July 20, 2020 Filed Jul 27, 2020 21:00 UTC Amendment | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 20,349 | $32.04 | $651,910.74 |
DisclosureSEC source: 0001437749-20-015787 · rdgdoc.xml · nonDerivative · entry 3 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,207 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $32.00 to $32.34. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| July 20, 2020 Filed Jul 27, 2020 21:00 UTC Amendment | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 18,496 | $8.86 | $163,874.56 |
DisclosureSEC source: 0001437749-20-015787 · rdgdoc.xml · nonDerivative · entry 2 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 292,556 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. Read SEC document |
| July 20, 2020 Filed Jul 27, 2020 21:00 UTC Amendment | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 1,853 | $4.00 | $7,412.00 |
DisclosureSEC source: 0001437749-20-015787 · rdgdoc.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,060 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. Read SEC document |
| July 17, 2020 Filed Jul 28, 2020 20:06 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 9 | $45.06 | $405.54 |
DisclosureSEC source: 0001447362-20-000157 · wf-form4_159596669669938.xml · nonDerivative · entry 3 Anderson Bonnie H · CIK 0001588970 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By trust Disclosed balance after: 21,723 F1 · kind: The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on March 17, 2020. F3 · ownership.nature: Held by the Bonnie H. Anderson Living Trust, or the Anderson Trust. The Reporting Person is the trustee of the Anderson Trust. Read SEC document |
| July 17, 2020 Filed Jul 28, 2020 20:06 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 1,763 | $44.00 | $77,572.00 |
DisclosureSEC source: 0001447362-20-000157 · wf-form4_159596669669938.xml · nonDerivative · entry 2 Anderson Bonnie H · CIK 0001588970 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By trust Disclosed balance after: 21,732 F1 · kind: The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on March 17, 2020. F4 · price: This transaction was executed in multiple trades at prices ranging from $43.61 to $44.52, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by the Bonnie H. Anderson Living Trust, or the Anderson Trust. The Reporting Person is the trustee of the Anderson Trust. Read SEC document |
| July 17, 2020 Filed Jul 28, 2020 20:06 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 1,228 | $42.90 | $52,681.20 |
DisclosureSEC source: 0001447362-20-000157 · wf-form4_159596669669938.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By trust Disclosed balance after: 23,495 F1 · kind: The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on March 17, 2020. F2 · price: This transaction was executed in multiple trades at prices ranging from $42.51 to $43.14, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by the Bonnie H. Anderson Living Trust, or the Anderson Trust. The Reporting Person is the trustee of the Anderson Trust. Read SEC document |
| July 16, 2020 Filed Jul 28, 2020 20:48 UTC Amendment | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 9 | $45.06 | $405.54 |
DisclosureSEC source: 0001447362-20-000159 · wf-form4a_159596921479704.xml · nonDerivative · entry 3 Anderson Bonnie H · CIK 0001588970 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By trust Disclosed balance after: 21,723 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on March 17, 2020. F3 · ownership.nature: Held by the Bonnie H. Anderson Living Trust, or the Anderson Trust. The Reporting Person is the trustee of the Anderson Trust. Read SEC document |
| July 16, 2020 Filed Jul 28, 2020 20:48 UTC Amendment | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 1,763 | $44.00 | $77,572.00 |
DisclosureSEC source: 0001447362-20-000159 · wf-form4a_159596921479704.xml · nonDerivative · entry 2 Anderson Bonnie H · CIK 0001588970 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By trust Disclosed balance after: 21,732 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on March 17, 2020. F4 · price: This transaction was executed in multiple trades at prices ranging from $43.61 to $44.52, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by the Bonnie H. Anderson Living Trust, or the Anderson Trust. The Reporting Person is the trustee of the Anderson Trust. Read SEC document |
| July 16, 2020 Filed Jul 28, 2020 20:48 UTC Amendment | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 1,228 | $42.90 | $52,681.20 |
DisclosureSEC source: 0001447362-20-000159 · wf-form4a_159596921479704.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By trust Disclosed balance after: 23,495 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on March 17, 2020. F2 · price: This transaction was executed in multiple trades at prices ranging from $42.51 to $43.14, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by the Bonnie H. Anderson Living Trust, or the Anderson Trust. The Reporting Person is the trustee of the Anderson Trust. Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 20:23 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 6,000 | $40.00 | $240,000.00 |
DisclosureSEC source: 0001447362-20-000127 · wf-form4_159242537312017.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By trust Disclosed balance after: 24,723 F1 · kind: The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on March 17, 2020. F2 · ownership.nature: Held by the Bonnie H. Anderson Living Trust, or the Anderson Trust. The Reporting Person is the trustee of the Anderson Trust. Read SEC document |
| June 10, 2020 Filed Jun 11, 2020 23:06 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $4.00 | $0.00 |
DisclosureSEC source: 0001384101-20-000099 · wf-form4_159191678078425.xml · derivative · entry 4 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,853 Underlying: Common Stock · 20,000 shares Expires 2023-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. F3 · shares: On February 5, 2013, the Reporting Person was issued 3 stock options which have different vesting dates, all of which are vested. These options include: (1) 112,500, of which 25,000 options remain, (2) 12,500, of which none remain and (3) 24,112, of which 20,000 were exercised on 6/10/2020 and 1,853 remain. F4 · derivative.exercise_date: The options are fully vested. Read SEC document |
| June 10, 2020 Filed Jun 11, 2020 23:06 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 20,000 | $26.56 | $531,260.00 |
DisclosureSEC source: 0001384101-20-000099 · wf-form4_159191678078425.xml · nonDerivative · entry 2 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,207 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $26.15 to $27.01. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| June 10, 2020 Filed Jun 11, 2020 23:06 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 20,000 | $4.00 | $80,000.00 |
DisclosureSEC source: 0001384101-20-000099 · wf-form4_159191678078425.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 292,207 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. Read SEC document |
| June 04, 2020 Filed Jun 8, 2020 16:19 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | GrantStock option (right to buy) · Derivative | 8,000 | $0.00 Strike: $37.50 | $0.00 |
DisclosureSEC source: 0001447362-20-000105 · wf-form4_159163315346347.xml · derivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires 2030-06-03 Read SEC document |
| June 02, 2020 Filed Jun 4, 2020 20:09 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 1,976 | $26.01 | $51,395.76 |
DisclosureSEC source: 0001384101-20-000074 · wf-form4_159130133957126.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,207 F1 · kind: The reporting person is reporting the withholding of 988 and 988 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 1,875 and 1,875 Restricted Stock Units, respectively granted on March 2, 2018 and February 28, 2019, respectively, and does not represent a sale by the reporting person. Read SEC document |
| May 12, 2020 Filed May 14, 2020 20:09 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 4,000 | $35.00 | $140,000.00 |
DisclosureSEC source: 0001447362-20-000064 · wf-form4_158948696880092.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By trust Disclosed balance after: 30,723 F1 · kind: The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on March 17, 2020. F2 · ownership.nature: Held by the Bonnie H. Anderson Living Trust, or the Anderson Trust. The Reporting Person is the trustee of the Anderson Trust. Read SEC document |
| May 11, 2020 Filed May 13, 2020 20:47 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 20,000 | $4.00 Strike: $4.00 | $80,000.00 |
DisclosureSEC source: 0001384101-20-000060 · wf-form4_158940284059359.xml · derivative · entry 7 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,853 Underlying: Common Stock · 20,000 shares Expires 2023-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · shares: On February 5, 2013, the Reporting Person was issued 3 stock options which have different vesting dates, all of which are vested. These options include: (1) 112,500, of which 5,241 shares are exercised on 5/11/2020 and 25,000 options remain, (2) 12,500, of which 12,500 are exercised on 5/11/2020 and none remain and (3) 24,112, of which 2,259 were exercised on 5/11/2020 and 21,853 remain. F6 · derivative.exercise_date: The options are fully vested. Read SEC document |
| May 11, 2020 Filed May 13, 2020 20:47 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantStock Option (right to buy) · Derivative | 10,920 | $0.00 Strike: $26.55 | $0.00 |
DisclosureSEC source: 0001384101-20-000060 · wf-form4_158940284059359.xml · derivative · entry 6 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,920 Underlying: Common Stock · 10,920 shares Expires 2030-05-10 F4 · derivative.exercise_date: The stock options awarded on May 11, 2020 vest 24 months from May 1, 2020 subject to continuing employment of the Reporting Person on the vesting date. Read SEC document |
| May 11, 2020 Filed May 13, 2020 20:47 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 200 | $27.10 | $5,420.00 |
DisclosureSEC source: 0001384101-20-000060 · wf-form4_158940284059359.xml · nonDerivative · entry 4 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,183 F2 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. Read SEC document |
| May 11, 2020 Filed May 13, 2020 20:47 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 19,800 | $26.66 | $527,913.54 |
DisclosureSEC source: 0001384101-20-000060 · wf-form4_158940284059359.xml · nonDerivative · entry 3 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,383 F2 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $26.08 to $27.03. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| May 11, 2020 Filed May 13, 2020 20:47 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 20,000 | $4.00 | $80,000.00 |
DisclosureSEC source: 0001384101-20-000060 · wf-form4_158940284059359.xml · nonDerivative · entry 2 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 294,183 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. Read SEC document |
| May 11, 2020 Filed May 13, 2020 20:47 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantCommon Stock | 1,870 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-20-000060 · wf-form4_158940284059359.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,183 F1 · kind: Restricted stock units awarded on May 11, 2020 vest 24 months from May 1, 2020 subject to continuing employment of the Reporting Person on the vesting date. Read SEC document |
| April 30, 2020 Filed May 4, 2020 20:46 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 462 | $31.10 | $14,368.20 |
DisclosureSEC source: 0001447362-20-000045 · wf-form4_158862515278176.xml · nonDerivative · entry 2 Anderson Bonnie H · CIK 0001588970 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By trust Disclosed balance after: 34,723 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on March 17, 2020. F4 · price: This transaction was executed in multiple trades at prices ranging from $30.73 to $31.52, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by the Bonnie H. Anderson Living Trust, or the Anderson Trust. The Reporting Person is the trustee of the Anderson Trust. Read SEC document |
| April 30, 2020 Filed May 4, 2020 20:46 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 2,538 | $30.09 | $76,368.42 |
DisclosureSEC source: 0001447362-20-000045 · wf-form4_158862515278176.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By trust Disclosed balance after: 35,185 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on March 17, 2020. F2 · price: This transaction was executed in multiple trades at prices ranging from $29.59 to $30.38, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by the Bonnie H. Anderson Living Trust, or the Anderson Trust. The Reporting Person is the trustee of the Anderson Trust. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.